Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapleural Docetaxel for Malignant Pleural Effusion in NSCLC
NCT03394105Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Jul 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in malignant pleural effusion (MPE), sponsored by Asan Medical Center. Started Jul 2016; status: completed.
02
Drugs
docetaxel
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT03394105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03394105.